Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth H Strasser

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
Cardiology|May 14, 2015
Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone on Peripheral Vessel Function and Clinical Parameters in Nondiabetic Patients: A Double-Center, Randomized Controlled Pilot TrialMarian Christoph, Joerg Herold, Anna Berg-Holldack, et al.
Journal of Molecular and Cellular Cardiology|April 18, 2008
The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endotheliumCarsten Wunderlich, Kristin Schober, Alexander Schmeisser, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 29, 2015
Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillationChristian Pfluecke, Daniel Tarnowski, Lina Plichta, et al.
European Heart Journal. Acute Cardiovascular Care|November 21, 2018
Long term survival after early unloading with Impella CP<sup>®</sup> in acute myocardial infarction complicated by cardiogenic shockTobias Loehn, William W O'Neill, Bjoern Lange, et al.
Heart and Vessels|February 13, 2014
Effects of the PPARγ agonist pioglitazone on coronary atherosclerotic plaque composition and plaque progression in non-diabetic patients: a double-center, randomized controlled VH-IVUS pilot-trialMarian Christoph, Joerg Herold, Anna Berg-Holldack, et al.
Platelets|March 14, 2017
Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillationDaniel Tarnowski, David M Poitz, Lina Plichta, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 28, 2017
Reversal of the platelet inhibitory effect of the P2Y<sub>12</sub> inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issueLisa Schoener, Stefanie Jellinghaus, Bernhardt Richter, et al.
Journal of Critical Care|August 3, 2016
Heart-type fatty acid-binding protein and myocardial creatine kinase enable rapid risk stratification in normotensive patients with pulmonary embolismMartin Langer, Mathias Forkmann, Utz Richter, et al.
Platelets|October 14, 2016
Association of platelet activation markers with recurrence of atrial fibrillation after pulmonary vein isolationChristian Pfluecke, Lina Plichta, Daniel Tarnowski, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 12, 2017
Reduction of atrial fibrillation burden by pulmonary vein isolation leads to a decrease of CD11b expression on inflammatory cellsDaniel Tarnowski, Lina Plichta, Mathias Forkmann, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Cardiology|May 14, 2015
Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone on Peripheral Vessel Function and Clinical Parameters in Nondiabetic Patients: A Double-Center, Randomized Controlled Pilot TrialMarian Christoph, Joerg Herold, Anna Berg-Holldack, et al.
Journal of Molecular and Cellular Cardiology|April 18, 2008
The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endotheliumCarsten Wunderlich, Kristin Schober, Alexander Schmeisser, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 29, 2015
Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillationChristian Pfluecke, Daniel Tarnowski, Lina Plichta, et al.
European Heart Journal. Acute Cardiovascular Care|November 21, 2018
Long term survival after early unloading with Impella CP<sup>®</sup> in acute myocardial infarction complicated by cardiogenic shockTobias Loehn, William W O'Neill, Bjoern Lange, et al.
Heart and Vessels|February 13, 2014
Effects of the PPARγ agonist pioglitazone on coronary atherosclerotic plaque composition and plaque progression in non-diabetic patients: a double-center, randomized controlled VH-IVUS pilot-trialMarian Christoph, Joerg Herold, Anna Berg-Holldack, et al.
Platelets|March 14, 2017
Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillationDaniel Tarnowski, David M Poitz, Lina Plichta, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 28, 2017
Reversal of the platelet inhibitory effect of the P2Y<sub>12</sub> inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issueLisa Schoener, Stefanie Jellinghaus, Bernhardt Richter, et al.
Journal of Critical Care|August 3, 2016
Heart-type fatty acid-binding protein and myocardial creatine kinase enable rapid risk stratification in normotensive patients with pulmonary embolismMartin Langer, Mathias Forkmann, Utz Richter, et al.
Platelets|October 14, 2016
Association of platelet activation markers with recurrence of atrial fibrillation after pulmonary vein isolationChristian Pfluecke, Lina Plichta, Daniel Tarnowski, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 12, 2017
Reduction of atrial fibrillation burden by pulmonary vein isolation leads to a decrease of CD11b expression on inflammatory cellsDaniel Tarnowski, Lina Plichta, Mathias Forkmann, et al.
Pageof 17